Daily non-political popular news in brief.

Preventing or reducing enlarged heart may decrease risk for diabetes

High-blood-pressure patients treated for enlarged heart who have regression or prevention of LVH may also have a better chance of preventing diabetes. Led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the research is published in the November Hypertension, a journal of the American Heart Association.

Read more »

Keywords: preventing, reducing, enlarged, heart, decrease, risk, diabetes, diabete

« Previous | Next »

Similar news on "Preventing or reducing enlarged heart may decrease risk for diabetes":

1. Preventing or reducing enlarged heart decreases risk of heart failure
   09-12-2007 · EurekAlert!
   For high-blood-pressure patients, preventing or reducing enlarged heart reduces risk of heart failure. The study is published in the Sept. 4 Annals of Internal Medicine and led by physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City.
   Similar news · Read more »
   
2. Less sugary drinks during childhood may cut disease risk
   12-18-2006 · EurekAlert!
   Symptoms of heart disease and diabetes usually seen in adults are increasingly being found in adolescents according to a longitudinal study, which suggests that reducing the intake of sugar-sweetened beverages during childhood may lessen the risk of chronic disease in later life.
   Similar news · Read more »
   
3. Older blacks and Latinos still lag whites in controlling diabetes
   09-24-2007 · EurekAlert!
   Despite decades of advances in diabetes care, African-Americans and Latinos are still far less likely than whites to have their blood sugar under control, even with the help of medications, a new national study finds. That puts them at a much higher risk of blindness, heart attack, kidney failure and other long-term diabetes complications. But the study also suggests opportunities to decrease the disparities.
   Similar news · Read more »
   
4. Stanford analysis shows little difference in risk rates for angioplasty, bypass procedures
   10-15-2007 · EurekAlert!
   Patients with heart disease who undergo coronary angioplasty have an equivalent risk of death and heart attack as patients who undergo coronary bypass surgery, according to Stanford University School of Medicine researchers. The researchers also found that the survival rates for bypass surgery and angioplasty were similar for patients with diabetes, refuting previous reports that angioplasty was associated with a significantly higher risk of death among diabetic patients.
   Similar news · Read more »
   
5. Link between obesity and enlarged heart discovered by University of Arizona researchers
   06-19-2007 · EurekAlert!
   Excessive body weight is associated with Left Ventricular Hypertrophy, a thickening of the heart muscle in the left ventricle, the heart's pumping chamber. The largest study of its kind helps explain why excessive body weight increases the risk for heart disease.
   Similar news · Read more »
   
6. Apple consumers reap heart-health benefits thanks to flavonoid content, says new research
   03-15-2007 · EurekAlert!
   A new study of more than 34,000 women, published in the March 2007 American Journal of Clinical Nutrition, found flavonoid-rich apples were found to be one of three foods that decrease the risk of mortality for both coronary heart disease (CHD) and cardiovascular disease (CVD) among post-menopausal women.
   Similar news · Read more »
   
7. Advance in understanding of blood pressure gene could lead to new treatments
   02-04-2007 · EurekAlert!
   Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
   Similar news · Read more »
   
8. Light activity can help avoid chronic disease
   06-11-2007 · EurekAlert!
   Reducing time spent sitting and increasing light physical activity has important health benefits that may reduce the risk of diabetes and other cardiovascular diseases.
   Similar news · Read more »
   
9. Children who learn heart healthy eating habits lower heart disease risk
   09-11-2007 · EurekAlert!
   A new study in Circulation confirms that when young children learn about heart healthy eating habits, it can strongly influence their heart disease risk later in life. A child's fat intake, primarily reduction in intake of foods rich in saturated fat, was found to be one of the greatest influencing factors in reducing cholesterol levels.
   Similar news · Read more »
   
10. Study identifies glucose 'sensor' that plays dual role in glucose metabolism and fat synthesis
    12-26-2006 · EurekAlert!
    In a new study, scientists at the Scripps Research Institute have described for the first time a glucose-activated sensor that acts as a switch to decrease production of endogenous glucose in the liver, and increase conversion of glucose to fat for storage in adipose tissue. This dual action makes the sensor, Liver X Receptor, a potential target for new therapies aimed at obesity and diabetes. The research may also have implications for heart disease and stroke.
    Similar news · Read more »